Literature DB >> 31229555

Close encounters between Trypanosoma cruzi and the host mammalian cell: Lessons from genome-wide expression studies.

Antonio Edson R Oliveira1, Viviane Grazielle-Silva1, Ludmila R P Ferreira2, Santuza M R Teixeira3.   

Abstract

Trypanosoma cruzi is the etiologic agent of Chagas disease, a life-threatening disease that affects different tissues. Within its mammalian host, T. cruzi develops molecular strategies for successful invasion of different cell types and adaptation to the intracellular environment. Conversely, the host cell responds to the infection by activating intracellular pathways to control parasite replication. Here, we reviewed genome-wide expression studies based on microarray and RNA-seq data from both parasite and host genes generated from animal models of infection as well as from Chagas disease patients. As expected, analyses of T. cruzi genes highlighted changes related to parasite energy metabolism and cell surface molecules, whereas host cell transcriptome emphasized the role of immune response genes. Besides allowing a better understanding of mechanisms behind the pathogenesis of Chagas disease, these studies provide essential information for the development of new therapies as well as biomarkers for diagnosis and assessment of disease progression.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31229555     DOI: 10.1016/j.ygeno.2019.06.015

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  7 in total

Review 1.  MicroRNAs: master regulators in host-parasitic protist interactions.

Authors:  Maura Rojas-Pirela; Diego Andrade-Alviárez; Lisvaneth Medina; Christian Castillo; Ana Liempi; Jesús Guerrero-Muñoz; Yessica Ortega; Juan Diego Maya; Verónica Rojas; Wilfredo Quiñones; Paul A Michels; Ulrike Kemmerling
Journal:  Open Biol       Date:  2022-06-15       Impact factor: 7.124

Review 2.  Experimental Strategies to Explore Drug Action and Resistance in Kinetoplastid Parasites.

Authors:  Magali Van den Kerkhof; Yann G-J Sterckx; Philippe Leprohon; Louis Maes; Guy Caljon
Journal:  Microorganisms       Date:  2020-06-24

Review 3.  All Roads Lead to Cytosol: Trypanosoma cruzi Multi-Strategic Approach to Invasion.

Authors:  Gabriel Ferri; Martin M Edreira
Journal:  Front Cell Infect Microbiol       Date:  2021-03-05       Impact factor: 5.293

4.  Co-Therapy of Albendazole and Dexamethasone Reduces Pathological Changes in the Cerebral Parenchyma of Th-1 and Th-2 Dominant Mice Heavily Infected with Angiostrongylus cantonensis: Histopathological and RNA-seq Analyses.

Authors:  Kai-Yuan Jhan; Chien-Ju Cheng; Shih-Ming Jung; Yi-Jen Lai; Kuang-Yao Chen; Lian-Chen Wang
Journal:  Biomolecules       Date:  2021-04-06

5.  Different Transcriptomic Response to T. cruzi Infection in hiPSC-Derived Cardiomyocytes From Chagas Disease Patients With and Without Chronic Cardiomyopathy.

Authors:  Theo G M Oliveira; Gabriela Venturini; Juliana M Alvim; Larissa L Feijó; Carla L Dinardo; Ester C Sabino; Jonathan G Seidman; Christine E Seidman; Jose E Krieger; Alexandre C Pereira
Journal:  Front Cell Infect Microbiol       Date:  2022-07-07       Impact factor: 6.073

6.  Kinetic Characterization and Inhibition of Trypanosoma cruzi Hypoxanthine-Guanine Phosphoribosyltransferases.

Authors:  Kayla Glockzin; Demetrios Kostomiris; Yacoba V T Minnow; Kajitha Suthagar; Keith Clinch; Sinan Gai; Joshua N Buckler; Vern L Schramm; Peter C Tyler; Thomas D Meek; Ardala Katzfuss
Journal:  Biochemistry       Date:  2022-09-15       Impact factor: 3.321

7.  Gene expression network analyses during infection with virulent and avirulent Trypanosoma cruzi strains unveil a role for fibroblasts in neutrophil recruitment and activation.

Authors:  Antonio Edson R Oliveira; Milton C A Pereira; Ashton T Belew; Ludmila R P Ferreira; Larissa M N Pereira; Eula G A Neves; Maria do Carmo P Nunes; Barbara A Burleigh; Walderez O Dutra; Najib M El-Sayed; Ricardo T Gazzinelli; Santuza M R Teixeira
Journal:  PLoS Pathog       Date:  2020-08-18       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.